Closing of Previously Announced Restructuring Transaction in Connection with CCAA Proceedings

Closing of Previously Announced Restructuring Transaction in Connection with CCAA Proceedings

Premier Health of America INC. (TSX-V: PHA) ("Premier Health" or the "Company") announces that, in connection with the restructuring proceedings initiated on June 23, 2026 by the Royal Bank of Canada (the "Applicant") in its capacity as a secured creditor (the "CCAA Proceedings") and the Court-approved restructuring transaction announced on July 3, 2026, Polar Valley Investments Limited ("Polar") has successfully closed the acquisition of all of the equity interests in three affiliates of the Company, namely Solutions Staffing Inc. ("SSI"), Canadian Health Care Agency Ltd. ("CHCA") and Premier Soin Nordik Inc. Premier Health Nordik Inc. ("Nordik Québec") (the "Transaction").

As a result of the Transaction, Polar became the sole holder of the securities of SSI, CHCA and Nordik Québec. Each of SSI, CHCA and Nordik Québec retained the assets and liabilities necessary to continue the going concern operations of their respective businesses and ceased to be debtors in the CCAA Proceedings.

In connection with the closing of the Transaction, Guy D'Aoust has ceased to act as Interim Chief Executive Officer of the Company.

Clients of SSI, CHCA and Nordik Québec should expect no changes to day-to-day operations and service levels. SSI, CHCA and Nordik Québec remain focused on delivering reliable, high-quality healthcare solutions and ensuring continuity of service for the organizations and communities served.

The CCAA Proceedings remain ongoing, as FTI Consulting Canada Inc., in its capacity as Court-appointed monitor (the "Monitor"), addresses the Company's remaining assets, liabilities, and obligations, and works toward winding down the Company's corporate structure in anticipation of terminating the CCAA Proceedings.

Documents relating to the restructuring process, such as Court orders and Monitor's reports, are available on the Monitor's website at https://cfcanada.fticonsulting.com/PHA. For more comprehensive information regarding the CCAA Proceedings and the Transaction, readers are invited to consult the full text of all of these documents.

Trading in the Company's common shares on the TSX Venture Exchange ("TSXV") has been halted. The common shares will remain halted until such date that the TSXV determines.

Forward-Looking Information

Certain statements in the preceding may constitute forward-looking statements, including the continuance of the operations of the Company and the date until which trading in the common shares will remain halted. These statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, to be materially different from any future result, performance or achievement expressed or implied by such forward-looking statements. These factors include the inability to successfully complete the SISP for the remaining assets of the Company, operational disruptions arising from restrictions imposed during the CCAA proceedings, continued suspension of trading of the common shares, and other risks and uncertainties discussed in the management discussion and analysis section of the Company's interim and most recent annual financial statement. There can be no assurance that such forward looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.

For Further Information Please Contact:

 Mr. Frédéric St-Cyr
 Interim Chief Financial Officer
 Premier Health of America Inc.
 fstcyr@premierhealth.ca / 1 800 231 9916


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PHA:CC
The Conversation (0)
Premier Health of America

Premier Health of America

Modernizing Healthcare Staffing with Automated, On-Demand Services

Modernizing Healthcare Staffing with Automated, On-Demand Services Keep Reading...
Seegnal (TSXV:SEGN)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...
Cardiologist wearing virtual reality glasses.

Top 3 Medical Device ETFs for Investors in 2026

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug Administration (FDA).Wearable medical devices and the use of artificial intelligence in medical... Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...

Interactive Chart

Latest Press Releases

Related News